1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
(
- Contribution to journal › Article
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
(
- Contribution to journal › Article
- 2021
-
Mark
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care
(
- Contribution to journal › Scientific review
-
Mark
FRMD6 has tumor suppressor functions in prostate cancer
2020) In Oncogene(
- Contribution to journal › Article
- 2018
-
Mark
Soluble HER3 predicts survival in bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
(
- Contribution to journal › Article
- 2017
-
Mark
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer : Extended Analysis of the Phase 3 PREVAIL Study
(
- Contribution to journal › Article
- 2016
-
Mark
Reduction of quality of life in prostate cancer patients : experience among 6200 men in the Nordic countries
(
- Contribution to journal › Article
-
Mark
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
(
- Contribution to journal › Article